Bicara Therapeutics Inc. (BCAX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $96.69M | -80.3% |
| 2024 | $489.71M | +112.5% |
| 2023 | $230.44M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $96.69M | -80.3% |
| 2024 | $489.71M | +112.5% |
| 2023 | $230.44M | — |